IL17A and rheumatoid arthritis: Although in vitro data have shown that synovium-derived MSCs isolated from rheumatoid arthritis patients display immunosuppressive properties comparable to the same MSCs isolated from healthy donors, upon treatment with IL-17 and/or TNF-α these cells increased proliferation of PHA-stimulated T cells in coculture [114].